Ventria's Child Health Product Recognized For Its Promise

Armen Hareyan's picture
Advertisement

A review article published in the Journal of Infection entitled, "Advances in defining etiology and new therapeutic approaches in acute diarrhea" [1], recognized Ventria's Child Health Product for its benefit to children who are suffering from acute diarrhea. The review was published online and is also available in the November print version.

Ventria's product is a medical food which can be added to standard electrolyte solutions to help children get better faster. The product was designed by researchers studying the advantages of breastfeeding for children. Ventria developed a method to affordably manufacture the important nutritional components of breast milk in rice. By replenishing these nutritional components, children suffering from diarrhea recovered quicker by one and a half days compared to the current standard electrolyte product used for rehydration during diarrhea.

Advertisement

William Greenough III, MD, Professor of Medicine at Johns Hopkins University and a world-renowned expert in pediatric diarrhea said "I am hoping that Ventria's product might be the first improvement that would be widely added to oral hydration solutions, which are consumed by at least half of the world's children".

In the United States there are an estimated 4.5 million hospital visits for childhood diarrhea. Globally, childhood diarrhea is the second leading killer of children under the age of 5, claiming 2 million lives annually.

"Diarrheal illnesses are a major reason for children seeing their physician and a major cause of emergency room visits," said Robert Wittler, MD, Professor, Pediatric Infectious Diseases, Kansas University School of Medicine at Wichita. "Oral rehydration is a safe and effective way to treat most diarrheal illnesses and this study confirms the advantages of adding proteins contained in breast milk to oral rehydration solution. This is an important study as decreasing the duration of diarrhea lessens the likelihood of children becoming significantly dehydrated and allows children to return to daycare and school quicker and their parents who work outside the home can return to work sooner."

"Ventria has been developing this product for several years and we are pleased with the recognition from leaders in the medical community. We anticipate a successful market introduction of this product so that we can make a positive contribution to child health on a global basis." said Scott Deeter, President and CEO, Ventria Bioscience.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement